CHICAGO, IL / ACCESS Newswire / January 22, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...

A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell clusters called tertiary lymphoid structures (TLSs) in response to foreign ...

The BAMs have a hydrophobic inner surface to prolong microbubble retention within biofluids and a hydrophilic outer layer ...

In practice, passive and active targeting are synergistically ... a potential biomarker and target for cancer therapy. Nanoparticles Targeting Proangiogenic Factors & Tumor Endothelial Cells ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company pioneering innovative cancer and viral infection ...

Stronger and clearer national leadership is urgently needed to improve cancer services, along with a greater focus on ...

The CHI-Zone is part of the ambitious 10-year Liverpool City Region Life Sciences Innovation Zone programme, expected to ...

Generating annual passive income of £100k isn’t going ... though I personally suspect Uber’s platform (with 161m monthly active customers) will be the central marketplace for robotaxi bookings.

Pfizer is expected to rebound in 2025 with growth stabilized and dividend growth to continue. Learn why PFE stock is a Buy.

The gene neuropilin2 regulates inhibitory neuron migration and excitatory neuron connections, essential for balanced brain activity.